Mercilon 0,15 mg and 0,02 mg Tablets
PDF Leaflet Revision Date: 14 October 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Oral contraception.
Dosage (summary)
One tablet daily for 28 days, starting on day 1 of the menstrual cycle.
Special Populations
- Breastfeeding women
- Women with a history of thrombosis
Pregnancy & Breastfeeding
Not recommended during breastfeeding; may affect milk production.
Key Drug Interactions
- Hepatic enzyme inducers (e.g., rifampicin)
- CYP3A4 inhibitors (e.g., ketoconazole)
Contraindications
- History of venous/arterial thrombosis
- Liver disease
- Pregnancy
Common side effects
- Nausea
- Headache
- Depressed mood
Counselling Points
- Take at the same time daily
- Use barrier method if tablets missed
- Report any severe headaches or vision changes
Serious warnings
- Increased risk of VTE
- Monitor for mood changes
Important Disclaimer
The Mercilon 0,15 mg and 0,02 mg Tablets professional information leaflet below is the property of Organon South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
